Medical Devices

Global Recombinant Human Erythropoietin (rhEPO) Market Insights, Forecast to 2025

  • QYR2792445
  • 119 Pages
  • October 2018
  • Medical Devices
Download Sample    Get Discount   
 
The process of supplying EPO externally, usually with the help of recombinant DNA technology in a cell culture, is known as rhEPO. rhEPO is used to treat anemia due to neural diseases, injuries, kidney diseases or cancer.

The global Recombinant Human Erythropoietin (rhEPO) market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Recombinant Human Erythropoietin (rhEPO) market based on company, product type, end user and key regions.

This report studies the global market size of Recombinant Human Erythropoietin (rhEPO) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Recombinant Human Erythropoietin (rhEPO) in these regions.

This research report categorizes the global Recombinant Human Erythropoietin (rhEPO) market by top players/brands, region, type and end user. This report also studies the global Recombinant Human Erythropoietin (rhEPO) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

3SBio

Shanghai Chemo

Chengdu Diao

NCPC Genetech

Kyowa Hakko Kirin

Shandong Kexing

Ahua Pharmaceutical

Biosidus

Dragon Pharma

Market size by Product

ESRD

Cancer

HIV

Wounds and neural disease

Market size by End User

Hospitals

Retail Pharmacies

Market size by Region

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

UK

Italy

Spain

Russia

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

The study objectives of this report are:

To study and analyze the global Recombinant Human Erythropoietin (rhEPO) market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.

To understand the structure of Recombinant Human Erythropoietin (rhEPO) market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Recombinant Human Erythropoietin (rhEPO) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

To project the value and sales volume of Recombinant Human Erythropoietin (rhEPO) submarkets, with respect to key regions.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Recombinant Human Erythropoietin (rhEPO) are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Recombinant Human Erythropoietin (rhEPO) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage

1.1 Recombinant Human Erythropoietin (rhEPO) Product

1.2 Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Recombinant Human Erythropoietin (rhEPO) Market Size Growth Rate by Product

1.4.2 ESRD

1.4.3 Cancer

1.4.4 HIV

1.4.5 Wounds and neural disease

1.5 Market by End User

1.5.1 Global Recombinant Human Erythropoietin (rhEPO) Market Size Growth Rate by End User

1.5.2 Hospitals

1.5.3 Retail Pharmacies

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Recombinant Human Erythropoietin (rhEPO) Market Size

2.1.1 Global Recombinant Human Erythropoietin (rhEPO) Revenue 2013-2025

2.1.2 Global Recombinant Human Erythropoietin (rhEPO) Sales 2013-2025

2.2 Recombinant Human Erythropoietin (rhEPO) Growth Rate by Regions

2.2.1 Global Recombinant Human Erythropoietin (rhEPO) Sales by Regions

2.2.2 Global Recombinant Human Erythropoietin (rhEPO) Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Recombinant Human Erythropoietin (rhEPO) Sales by Manufacturers

3.1.1 Recombinant Human Erythropoietin (rhEPO) Sales by Manufacturers

3.1.2 Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Manufacturers

3.1.3 Global Recombinant Human Erythropoietin (rhEPO) Market Concentration Ratio (CR5 and HHI)

3.2 Recombinant Human Erythropoietin (rhEPO) Revenue by Manufacturers

3.2.1 Recombinant Human Erythropoietin (rhEPO) Revenue by Manufacturers (2013-2018)

3.2.2 Recombinant Human Erythropoietin (rhEPO) Revenue Share by Manufacturers (2013-2018)

3.3 Recombinant Human Erythropoietin (rhEPO) Price by Manufacturers

3.4 Recombinant Human Erythropoietin (rhEPO) Manufacturing Base Distribution, Product Types

3.4.1 Recombinant Human Erythropoietin (rhEPO) Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Recombinant Human Erythropoietin (rhEPO) Product Type

3.4.3 Date of International Manufacturers Enter into Recombinant Human Erythropoietin (rhEPO) Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Recombinant Human Erythropoietin (rhEPO) Sales by Product

4.2 Global Recombinant Human Erythropoietin (rhEPO) Revenue by Product

4.3 Recombinant Human Erythropoietin (rhEPO) Price by Product

5 Breakdown Data by End User

5.1 Overview

5.2 Global Recombinant Human Erythropoietin (rhEPO) Breakdown Data by End User

6 North America

6.1 North America Recombinant Human Erythropoietin (rhEPO) by Countries

6.1.1 North America Recombinant Human Erythropoietin (rhEPO) Sales by Countries

6.1.2 North America Recombinant Human Erythropoietin (rhEPO) Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Recombinant Human Erythropoietin (rhEPO) by Product

6.3 North America Recombinant Human Erythropoietin (rhEPO) by End User

7 Europe

7.1 Europe Recombinant Human Erythropoietin (rhEPO) by Countries

7.1.1 Europe Recombinant Human Erythropoietin (rhEPO) Sales by Countries

7.1.2 Europe Recombinant Human Erythropoietin (rhEPO) Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Recombinant Human Erythropoietin (rhEPO) by Product

7.3 Europe Recombinant Human Erythropoietin (rhEPO) by End User

8 Asia Pacific

8.1 Asia Pacific Recombinant Human Erythropoietin (rhEPO) by Countries

8.1.1 Asia Pacific Recombinant Human Erythropoietin (rhEPO) Sales by Countries

8.1.2 Asia Pacific Recombinant Human Erythropoietin (rhEPO) Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Recombinant Human Erythropoietin (rhEPO) by Product

8.3 Asia Pacific Recombinant Human Erythropoietin (rhEPO) by End User

9 Central & South America

9.1 Central & South America Recombinant Human Erythropoietin (rhEPO) by Countries

9.1.1 Central & South America Recombinant Human Erythropoietin (rhEPO) Sales by Countries

9.1.2 Central & South America Recombinant Human Erythropoietin (rhEPO) Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Recombinant Human Erythropoietin (rhEPO) by Product

9.3 Central & South America Recombinant Human Erythropoietin (rhEPO) by End User

10 Middle East and Africa

10.1 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) by Countries

10.1.1 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Sales by Countries

10.1.2 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) by Product

10.3 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) by End User

11 Company Profiles

11.1 3SBio

11.1.1 3SBio Company Details

11.1.2 Company Business Overview

11.1.3 3SBio Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2013-2018)

11.1.4 3SBio Recombinant Human Erythropoietin (rhEPO) Products Offered

11.1.5 3SBio Recent Development

11.2 Shanghai Chemo

11.2.1 Shanghai Chemo Company Details

11.2.2 Company Business Overview

11.2.3 Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2013-2018)

11.2.4 Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Products Offered

11.2.5 Shanghai Chemo Recent Development

11.3 Chengdu Diao

11.3.1 Chengdu Diao Company Details

11.3.2 Company Business Overview

11.3.Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2013-2018)

11.3.4 Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Products Offered

11.3.5 Chengdu Diao Recent Development

11.4 NCPC Genetech

11.4.1 NCPC Genetech Company Details

11.4.2 Company Business Overview

11.4.3 NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2013-2018)

11.4.4 NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Products Offered

11.4.5 NCPC Genetech Recent Development

11.5 Kyowa Hakko Kirin

11.5.1 Kyowa Hakko Kirin Company Details

11.5.2 Company Business Overview

11.5.3 Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2013-2018)

11.5.4 Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Products Offered

11.5.5 Kyowa Hakko Kirin Recent Development

11.6 Shandong Kexing

11.6.1 Shandong Kexing Company Details

11.6.2 Company Business Overview

11.6.3 Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2013-2018)

11.6.4 Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Products Offered

11.6.5 Shandong Kexing Recent Development

11.7 Ahua Pharmaceutical

11.7.1 Ahua Pharmaceutical Company Details

11.7.2 Company Business Overview

11.7.3 Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2013-2018)

11.7.4 Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Products Offered

11.7.5 Ahua Pharmaceutical Recent Development

11.8 Biosidus

11.8.1 Biosidus Company Details

11.8.2 Company Business Overview

11.8.3 Biosidus Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2013-2018)

11.8.4 Biosidus Recombinant Human Erythropoietin (rhEPO) Products Offered

11.8.5 Biosidus Recent Development

11.9 Dragon Pharma

11.9.1 Dragon Pharma Company Details

11.9.2 Company Business Overview

11.9.3 Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2013-2018)

11.9.4 Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Products Offered

11.9.5 Dragon Pharma Recent Development

12 Future Forecast

12.1 Recombinant Human Erythropoietin (rhEPO) Market Forecast by Regions

12.1.1 Global Recombinant Human Erythropoietin (rhEPO) Sales Forecast by Regions 2018-2025

12.1.2 Global Recombinant Human Erythropoietin (rhEPO) Revenue Forecast by Regions 2018-2025

12.2 Recombinant Human Erythropoietin (rhEPO) Market Forecast by Product

12.2.1 Global Recombinant Human Erythropoietin (rhEPO) Sales Forecast by Product 2018-2025

12.2.2 Global Recombinant Human Erythropoietin (rhEPO) Revenue Forecast by Product 2018-2025

12.3 Recombinant Human Erythropoietin (rhEPO) Market Forecast by End User

12.4 North America Recombinant Human Erythropoietin (rhEPO) Forecast

12.5 Europe Recombinant Human Erythropoietin (rhEPO) Forecast

12.6 Asia Pacific Recombinant Human Erythropoietin (rhEPO) Forecast

12.7 Central & South America Recombinant Human Erythropoietin (rhEPO) Forecast

12.8 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers

13.2 Market Challenges

13.3 Market Risks/Restraints

13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis

14.2 Recombinant Human Erythropoietin (rhEPO) Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

List of Tables and Figures

Figure Recombinant Human Erythropoietin (rhEPO) Product Picture

Table Recombinant Human Erythropoietin (rhEPO) Market Segments

Table Key Manufacturers Recombinant Human Erythropoietin (rhEPO) Covered

Table Global Recombinant Human Erythropoietin (rhEPO) Market Size Growth Rate by Product 2018-2025 (K Units) & (Million US$)

Figure Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Product 2013-2025

Figure ESRD Product Picture

Table Major Manufacturers of ESRD

Figure Cancer Product Picture

Table Major Manufacturers of Cancer

Figure HIV Product Picture

Table Major Manufacturers of HIV

Figure Wounds and neural disease Product Picture

Table Major Manufacturers of Wounds and neural disease

Table Global Recombinant Human Erythropoietin (rhEPO) Market Size Growth Rate by End User 2018-2025 (K Units)

Figure Hospitals

Figure Retail Pharmacies

Figure Recombinant Human Erythropoietin (rhEPO) Report Years Considered

Figure Global Recombinant Human Erythropoietin (rhEPO) Market Size 2013-2025 (Million US$)

Figure Global Recombinant Human Erythropoietin (rhEPO) Sales 2013-2025 (K Units)

Table Global Recombinant Human Erythropoietin (rhEPO) Market Size by Regions 2013-2018 (K Units) & (Million US$)

Table Global Recombinant Human Erythropoietin (rhEPO) Sales by Regions 2013-2018 (K Units)

Table Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Regions 2013-2018

Figure Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Regions 2013-2018

Figure 2017 Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Regions

Table Global Recombinant Human Erythropoietin (rhEPO) Revenue by Regions 2013-2018 (Million US$)

Table Global Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Regions 2013-2018

Figure Global Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Regions 2013-2018

Figure 2017 Global Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Regions

Table Global Recombinant Human Erythropoietin (rhEPO) Sales by Manufacturers (2013-2018) (K Units)

Table Global Recombinant Human Erythropoietin (rhEPO) Sales Share by Manufacturers (2013-2018)

Figure Global Recombinant Human Erythropoietin (rhEPO) Sales Share by Manufacturers in 2017

Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Recombinant Human Erythropoietin (rhEPO) Revenue by Manufacturers (2013-2018) (Million USD)

Table Recombinant Human Erythropoietin (rhEPO) Revenue Share by Manufacturers (2013-2018)

Figure Recombinant Human Erythropoietin (rhEPO) Value Share by Manufacturers in 2017

Table Key Manufacturers Recombinant Human Erythropoietin (rhEPO) Price (2013-2018) (USD/Unit)

Table Recombinant Human Erythropoietin (rhEPO) Manufacturers Manufacturing Base Distribution and Headquarters

Table Manufacturers Recombinant Human Erythropoietin (rhEPO) Product Type

Table Date of International Manufacturers Enter into Recombinant Human Erythropoietin (rhEPO) Market

Table Manufacturers Mergers & Acquisitions, Expansion Plans

Table Global Recombinant Human Erythropoietin (rhEPO) Sales by Product (2013-2018) (K Units)

Table Global Recombinant Human Erythropoietin (rhEPO) Sales Share by Product (2013-2018)

Figure Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Product (2013-2018)

Figure Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Product in 2017

Table Global Recombinant Human Erythropoietin (rhEPO) Revenue by Product (2013-2018) (Million US$)

Table Global Recombinant Human Erythropoietin (rhEPO) Revenue Share by Product (2013-2018)

Figure Global Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Product (2013-2018)

Figure Global Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Product in 2017

Table Recombinant Human Erythropoietin (rhEPO) Price by Product 2013-2018 (USD/Unit)

Table Global Recombinant Human Erythropoietin (rhEPO) Sales by End User (2013-2018) (K Units)

Table Global Recombinant Human Erythropoietin (rhEPO) Sales Share by End User (2013-2018)

Figure Global Sales Recombinant Human Erythropoietin (rhEPO) Market Share by End User (2013-2018)

Figure Global Sales Recombinant Human Erythropoietin (rhEPO) Market Share by End User in 2017

Figure North America Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate 2013-2018 (K Units)

Figure North America Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate 2013-2018 (Million US$)

Table North America Recombinant Human Erythropoietin (rhEPO) Sales by Countries (2013-2018) (K Units)

Table North America Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Countries (2013-2018)

Figure 2017 North America Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Countries

Table North America Recombinant Human Erythropoietin (rhEPO) Revenue by Countries (2013-2018) (Million US$)

Table North America Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Countries (2013-2018)

Figure 2017 North America Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Countries

Figure United States Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure United States Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (K Units)

Figure Canada Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure Canada Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Figure Mexico Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure Mexico Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Table North America Recombinant Human Erythropoietin (rhEPO) Sales by Product (2013-2018) (K Units)

Table North America Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Product (2013-2018)

Figure 2017 North America Recombinant Human Erythropoietin (rhEPO) Market Share by Product

Table North America Recombinant Human Erythropoietin (rhEPO) Sales by End User (2013-2018) (K Units)

Table North America Recombinant Human Erythropoietin (rhEPO) Sales Market Share by End User (2013-2018)

Figure 2017 North America Recombinant Human Erythropoietin (rhEPO) Market Share by End User

Figure Europe Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate 2013-2018 (K Units)

Figure Europe Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate 2013-2018 (Million US$)

Table Europe Recombinant Human Erythropoietin (rhEPO) Sales by Countries (2013-2018) (K Units)

Table Europe Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Countries (2013-2018)

Figure 2017 Europe Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Countries

Table Europe Recombinant Human Erythropoietin (rhEPO) Revenue by Countries (2013-2018) (Million US$)

Table Europe Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Countries (2013-2018)

Figure 2017 Europe Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Countries

Figure Germany Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure Germany Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Figure France Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure France Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Figure UK Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure UK Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Figure Italy Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure Italy Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Figure Russia Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure Russia Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Table Europe Recombinant Human Erythropoietin (rhEPO) Sales by Product (2013-2018) (K Units)

Table Europe Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Product (2013-2018)

Figure 2017 Europe Recombinant Human Erythropoietin (rhEPO) Market Share by Product

Table Europe Recombinant Human Erythropoietin (rhEPO) Sales by End User (2013-2018) (K Units)

Table Europe Recombinant Human Erythropoietin (rhEPO) Sales Market Share by End User (2013-2018)

Figure 2017 Europe Recombinant Human Erythropoietin (rhEPO) Market Share by End User

Figure Asia Pacific Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate 2013-2018 (K Units)

Figure Asia Pacific Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate 2013-2018 (Million US$)

Table Asia Pacific Recombinant Human Erythropoietin (rhEPO) Sales by Countries (2013-2018) (K Units)

Table Asia Pacific Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Countries (2013-2018)

Figure 2017 Asia Pacific Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Countries

Table Asia Pacific Recombinant Human Erythropoietin (rhEPO) Revenue by Countries (2013-2018) (Million US$)

Table Asia Pacific Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Countries (2013-2018)

Figure 2017 Asia Pacific Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Countries

Figure China Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure China Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Figure Japan Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure Japan Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Figure Korea Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure Korea Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Figure India Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure India Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Figure Australia Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure Australia Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Figure Indonesia Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure Indonesia Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Figure Malaysia Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure Malaysia Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Figure Philippines Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure Philippines Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Figure Thailand Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure Thailand Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Figure Vietnam Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure Vietnam Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Figure Singapore Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure Singapore Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Table Asia Pacific Recombinant Human Erythropoietin (rhEPO) Sales by Product (2013-2018) (K Units)

Table Asia Pacific Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Product (2013-2018)

Figure 2017 Asia Pacific Recombinant Human Erythropoietin (rhEPO) Market Share by Product

Table Asia Pacific Recombinant Human Erythropoietin (rhEPO) Sales by End User (2013-2018) (K Units)

Table Asia Pacific Recombinant Human Erythropoietin (rhEPO) Sales Market Share by End User (2013-2018)

Figure 2017 Asia Pacific Recombinant Human Erythropoietin (rhEPO) Market Share by End User

Figure Central & South America Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate 2013-2018 (K Units)

Figure Central & South America Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate 2013-2018 (Million US$)

Table Central & South America Recombinant Human Erythropoietin (rhEPO) Sales by Countries (2013-2018) (K Units)

Table Central & South America Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Countries (2013-2018)

Figure 2017 Central & South America Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Countries

Table Central & South America Recombinant Human Erythropoietin (rhEPO) Revenue by Countries (2013-2018) (Million US$)

Table Central & South America Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Countries (2013-2018)

Figure 2017 Central & South America Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Countries

Figure Brazil Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure Brazil Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Figure Argentina Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure Argentina Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Table Central & South America Recombinant Human Erythropoietin (rhEPO) Sales by Product (2013-2018) (K Units)

Table Central & South America Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Product (2013-2018)

Figure 2017 Central & South America Recombinant Human Erythropoietin (rhEPO) Market Share by Product

Table Central & South America Recombinant Human Erythropoietin (rhEPO) Sales by End User (2013-2018) (K Units)

Table Central & South America Recombinant Human Erythropoietin (rhEPO) Sales Market Share by End User (2013-2018)

Figure 2017 Central & South America Recombinant Human Erythropoietin (rhEPO) Market Share by End User

Figure Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate 2013-2018 (K Units)

Figure Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate 2013-2018 (Million US$)

Table Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Sales by Countries (2013-2018) (K Units)

Table Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Countries (2013-2018)

Figure 2017 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Countries

Table Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Revenue by Countries (2013-2018) (Million US$)

Table Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Countries (2013-2018)

Figure 2017 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Countries

Figure GCC Countries Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure GCC Countries Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Figure Turkey Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure Turkey Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Figure Egypt Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure Egypt Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Figure South Africa Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate (2013-2018) (K Units)

Figure South Africa Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate (2013-2018) (Million US$)

Table Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Sales by Product (2013-2018) (K Units)

Table Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Product (2013-2018)

Figure 2017 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Market Share by Product

Table Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Sales by End User (2013-2018) (K Units)

Table Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Sales Market Share by End User (2013-2018)

Figure 2017 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Market Share by End User

Table 3SBio Company Details

Table 3SBio Recombinant Human Erythropoietin (rhEPO) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table 3SBio Recent Development

Table Shanghai Chemo Company Details

Table Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Shanghai Chemo Recent Development

Table Chengdu Diao Company Details

Table Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Chengdu Diao Recent Development

Table NCPC Genetech Company Details

Table NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table NCPC Genetech Recent Development

Table Kyowa Hakko Kirin Company Details

Table Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Kyowa Hakko Kirin Recent Development

Table Shandong Kexing Company Details

Table Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Shandong Kexing Recent Development

Table Ahua Pharmaceutical Company Details

Table Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Ahua Pharmaceutical Recent Development

Table Biosidus Company Details

Table Biosidus Recombinant Human Erythropoietin (rhEPO) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Biosidus Recent Development

Table Dragon Pharma Company Details

Table Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Dragon Pharma Recent Development

Table Global Recombinant Human Erythropoietin (rhEPO) Sales Forecast by Regions 2018-2025 (K Units)

Table Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share Forecast by Regions 2018-2025

Table Global Recombinant Human Erythropoietin (rhEPO) Revenue Forecast by Regions 2018-2025 (Million US$)

Table Global Recombinant Human Erythropoietin (rhEPO) Revenue Market Share Forecast by Regions 2018-2025

Table Global Recombinant Human Erythropoietin (rhEPO) Sales Forecast by Product 2018-2025 (K Units)

Table Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share Forecast by Product 2018-2025

Table Global Recombinant Human Erythropoietin (rhEPO) Revenue Forecast by Product 2018-2025 (Million US$)

Table Global Recombinant Human Erythropoietin (rhEPO) Revenue Market Share Forecast by Product 2018-2025

Table Global Recombinant Human Erythropoietin (rhEPO) Sales Forecast by End User 2018-2025 (K Units)

Table Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share Forecast by End User 2018-2025

Figure North America Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate Forecast (2018-2025) (K Units)

Figure North America Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate Forecast (2018-2025) (Million US$)

Figure Europe Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate Forecast (2018-2025) (K Units)

Figure Europe Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate Forecast (2018-2025) (Million US$)

Figure Asia Pacific Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate Forecast (2018-2025) (K Units)

Figure Asia Pacific Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate Forecast (2018-2025) (Million US$)

Figure Central & South America Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate Forecast (2018-2025) (K Units)

Figure Central & South America Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate Forecast (2018-2025) (Million US$)

Figure Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Sales Growth Rate Forecast (2018-2025) (K Units)

Figure Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Revenue Growth Rate Forecast (2018-2025) (Million US$)

Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016

Figure Forecast of Global Middle-Class Population, 2015 to 2030

Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016

Table Recombinant Human Erythropoietin (rhEPO) Value Chain

Table Recombinant Human Erythropoietin (rhEPO) Customers List

Table Recombinant Human Erythropoietin (rhEPO) Distributors List

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370